Atlassian filed an SEC disclosure while Raymond James Financial and Truist Financial issued new price objectives and target lifts.
1 report, 1 independent
Updated Aug 17
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Atlassian filed an SEC disclosure while Raymond James Financial and Truist Financial issued new price objectives and target lifts.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Atlassian
Australian enterprise software company
- Powell delivered dovish remarks at the Jackson Hole symposium on August 23, 2025, which are seen as benefiting growth-oriented technology stocks like Atlassian.
- Research findings published on September 25, 2026, indicate how productivity studies are informing disconnect laws and identifying major time sinks in meetings.
-
Raymond James Financial
American Investment Bank and Financial Services Firm
-
Truist Financial
American bank holding company, formerly known as BB&T Corporation
- MarketBeat aggregates data on Inventiva's stock, and Truist Financial has started coverage of the company.
- Bank of America boosted its price target and gave a buy rating for Guardian Pharmacy Services, Inc. on September 15, 2026. Truist Financial also boosted its target price and gave a buy rating on the same day.
Related events
- Cantor Fitzgerald and Citigroup raised their price targets on Atlassian stock on September 22, 2026.
- Truist Financial increased its price objective while First Citizens BancShares disclosed sales with the SEC.
- Treace Medical Concepts disclosed a purchase in an SEC filing, and Truist Financial increased its target price for the company.
- Truist Financial disclosed trading activity and issued price objective reports related to Edwards Lifesciences.
- Raymond James Financial set a high price target for Hammond Power Solutions, which was reported by MarketBeat.